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Long-term chloramphenicol- and ethidium bromide-treated chick embryo fibroblasts ynthesize large 
amounts of porphyrins from exogenously added a-aminolevulinic a id. The porphyrins consist mainly of 
uro- and heptacarboxyporphyrins and are retained within cells. Uroporphyria development is a time- 
dependent process which accompanies a step-wise decrease in the capacity of the mitochondrial respiratory 
chain. Upon removal of chloramphenicol from the medium, the pattern of porphyrin production readily 
returns to normal (mainly proto- and coproporphyrins found in the medium) while ethidium bromide- 
treated cells remain uroporphyric. The results suggest that impairment of mitochondrial functions in 
chicken by xenobiotics leads to uroporphyria development. 
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1. INTRODUCTION 
A variety of chemical compounds have been 
shown to induce porphyria in mammals and birds 
(review [l]). Among the xenobiotics tested, 
polyhalogenated aromatic hydrocarbons (PHA) 
are known to cause a massive production of uro- 
and heptacarboxyporphyrins in the liver of treated 
animals (review [2]). This type of porphyria is a 
time-dependent process which usually takes at least 
a week in birds [3]. It resembles asyndrome known 
in man as porphyria cutanea tarda, characterized 
by a massive accumulation of uroporphyrin in the 
liver and a marked uroporphyrinuria [4,5]. Ex- 
perimental uroporphyria can also be induced by 
PHA in chick embryo liver cells in culture [l]. 
When the cells are incubated in the presence of c- 
aminolevulinate (ALA), the development of 
uroporphyria is a function of the concentration of 
xenobiotics and appears over a period of less than 
24 h [6,7]. The mechanism whereby PHA induce 
uroporphyria in birds as well as mammals in vivo 
and in vitro is still obscure, but the data obtained 
thus far show that this phenomenon is specifically 
related to the reduction in activity of uropor- 
phyrinogen decarboxylase [2]. 
We have reported [S-10] that cultured chick em- 
bryo fibroblasts (CEP) are inherently resistant o 
the growth-inhibitory effect of chloramphenicol 
(CAP) and ethidium bromide (EtdBr), inhibitors 
of protein synthesis on mitoribosomes and 
mitochondrial DNA (mtDNA) replication and 
transcription, respectively. Long-term drug- 
treated cells are respiration-deficient and devoid of 
mitochondrial cytochromes b and au3. The protein 
moieties of these cytochromes are known to be 
coded for either completely (b) or in part (aa9 by 
mtDNA [ 111. In the course of a study on the effect 
of CAP and EtdBr on the mitochondrial 
cytochrome content of CEF, the syntheses of the 
heme precursor moieties of these proteins have 
been investigated. We here demonstrate that CAP 
and EtdBr induce uroporphyria in CEF incubated 
in the presence of exogenously-added ALA. It is a 
time-dependent process which is fully reversible 
when CAP but not EtdBr is eliminated from the 
culture medium. 
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2. MATERIALS AND METHODS 
Growth medium, sera and antibiotics were pur- 
chased from Gibco. CAP, EtdBr and ALA were 
obtained from Sigma. Porphyrin standards were 
from Porphyrin Products. Methanol and water 
(HPLC grade) were obtained from Fisher. 
Chick embryo fibroblasts were prepared as in [8] 
and propagated in Ham’s F12 medium sup- 
plemented with antibiotics, sera and uridine as in 
[12] and, where indicated, CAP (lOO/cg/ml) or 
EtdBr (0.4pg/ml). Cells in mid to late log phase 
were used to study the biosynthesis of porphyrins 
from ALA (1.2 mM). They were incubated in fresh 
growth medium without phenol red and harvested 
24 h later by trypsinization. The cells (2-6 x 10’) 
were washed twice with PBS and resuspended in 
2 ml distilled water. The cell suspension was ad- 
justed to pH 3.2 with saturated sodium acetate and 
the porphyrins extracted 3 times with 2 ml ethyl 
acetate-glacial acetic acid (4 : 1, v/v). The extracts 
were evaporated under nitrogen, the residues taken 
up in 500 /rl of 1 N HCl and centrifuged for 40 min 
at 15000 rpm. The porphyrins in 10 ml growth 
medium were similarly extracted 3 times with 5 ml 
ethyl acetate-glacial acetic acid at pH 3.2. Control 
experiments with various amounts of a mixture of 
porphyrins with 8-2 carboxyl groups revealed that 
the percent recovery of the extracted porphyrins 
varied from 80% (uroporphyrin) to 98% (pro- 
toporphyrin). Porphyrin composition was deter- 
mined by high-pressure liquid chromatography 
(HPLC) using a Lichrosorb RP-18 column (5 p) 
essentially as in [ 131. The experiments were per- 
formed with Model 334 Beckman Liquid 
Chromatograph. The eluting materials were 
detected by absorption at 404 nm using a Hitachi 
Spectrophotometer Model 155, recorded and the 
surface area computerized with a Perkin-Elmer 
Sigma 10. Uroporphyrin isomer analysis was per- 
formed as in [14] but modified by Dr A. Sasarman 
(personal communication). Cytochrome spectra 
were performed as in [8]. The protein concentra- 
tion was determined according to [15]. 
Table 1 
Porphyrin formation from exogenous ALA by control and long-term CAP- and EtdBr-treated chick 
embryo fibroblasts 
Drug Distribution and profile of porphyrins 
(pmol/mg cell protein) 
Cell Medium Total CS c7 (26 CS c4 c2 
None (8) 102 + 60 915 f 203 1017 f 183 I 61 29 0 0 0 12 
E 4 45 52 7 197 610 
CAP+ (8) 831 * 151 612 f 194 1443 * 282 I 630 199 0 0 0 2 
E 49 182 88 23 83 187 
EtdBr+ (5) 870 + 477 424 + 200 1294 f 574 I 626 237 4 0 0 3 
E 16 78 4 0 73 253 
EtdBr- (4) 579 f 335 580 f 123 1159 f 387 I 432 138 2 0 0 7 
E 36 169 82 38 72 183 
CAP- (4) 384 f 113 672 + 260 1056 + 319 I 279 97 1 0 0 7 
(24 h) E 23 96 29 4 154 366 
CAP- (2) 84 f 25 565 + 103 649 f 79 I 38 21 1 1 1 22 
(48 h) E 0 064 0 210 291 
Total porphyrin content of cells and medium and their profile were determined by HPLC [ 131. Values 
represent the mean + SD of individual experiments. The number of experiments are given in 
parentheses. +, cells maintained in the presence of the drugs for more than 21 days; , cells shifted to 
drug-free medium for 24 or 48 h and 21 days (EtdBr); I, intracellular; E, extracellular; Cs-C2, 
porphyrins with 8-2 carboxyl groups 
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3. RESULTS 
When cultivated in the presence of ALA, control 
CEF synthesized large amounts of porphyrins 
(table 1). They consisted mainly of proto- (6lolo) 
and coproporphyrins (19%) and were almost ex- 
clusively located in the medium. Small amounts of 
porph~ins with 8-2 carboxyl groups were also 
detected. Uro- and heptacarboxyporphyrins were 
the major heme precursor present in the cells. 
These observations bear a close resemblance to 
those reported recently concerning cultured chick 
embryo liver cells incubated in the presence of 
ALA [6,7]. 
The amount, distribution and profile of por- 
phyrins were found to be substantially affected in 
long-term CAP- and EtdBr-treated CEF. As 
shown in table 1, drug-treated cells synthesized on 
average 20-40% more porphyrins than control 
cells. Further, more than 60% of the total amount 
of porphyrins produced were retained within cells. 
The latter appeared to contain predominantly por- 
phyrins, rather than porphyrinogens, since the col- 
or of the freshly trypsinized cells was reddish. The 
type III isomers of uro- (5Oqo) and heptacarbox- 
yporphyrins (2Y70) constituted the major heme 
precursors synthesized and were found primarily in 
the cells. Accumulation of proto- and copropor- 
phyrins was greatly reduced compared to control 
cells and these compounds were found exclusively 
in the medium. Variable amounts of porphyrins 
with 8-2 carboxyl groups were also present in the 
medium, 
The development of uroporphyria in CEF was 
found to be a slow process (fig.l) which began at 
about day 10, after 6-7 cell generations, after the 
mitochondrial respiratory capacity of the cells had 
been severely perturbed [16]. Uroporphyria was 
clearly established at day 20,6-7 generations later. 
The inhibitory effect of CAP and EtdBr on the 
synthesis of proteins coded for by mtDNA resulted 
in the formation of mitochondria devoid of a func- 
tional respiratory chain. This is illustrated by com- 
paring the reduced-minus-oxidized spectra of total 
cytochromes of control cells to those of the drug- 
treated cells. As shown in fig.2, the characteristic 
bands of cytochromes aa (at 603 nm) and b 
(shoulder at 562 nm) (trace A) disappeared in 
CAP- and EtdBr-treated cells (traces B and E, 
respectively) while that of cytochrome c (at 
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Fig. 1. Time-dependent porphyrin formation from 
exogenous ALA by control (A) and long-term CAP (B)- 
and EtdBr (C)-treated CEF. Ex~rimental conditions 
were as in section 2. Values represent the mean + SD of 
3 individual experiments, except for day 35 which 
represent the mean +_ SD of 8 (A and B) and 4 (C) 
different experiments performed between days 30 and 
40. (w) Uro- and heptacarboxyporphyrins, (o--+) 
copro- and protoporphyrins. 
548 nm), a nuclearly coded protein, is still present. 
The distribution as well as the profile of the por- 
phyrins were found to return to normal when CAP 
was eliminated from the culture medium (table 1). 
These time-dependent processes were completed at 
48 h and accompanied the restoration of the syn- 
thesis of mtDNA-coded proteins as illustrated by 
the reappearance of the absorption bands of 
mitochondrial cytochromes aa and b (fig.2, traces 
C,D). In contrast, when EtdBr was removed from 
the culture medium, protein synthesis on 
mitoribosomes was not restored (fig.2, trace F) 
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Fig.2. The reduced-minus-oxidized spectra at liquid 
nitrogen temperature of the cytochromes of control (A) 
and long-term CAP (B)- and EtdBr (F)-treated CEF. (C 
and D) CAM-treated ceils shifted to drug-free medium 
for 24 and 48 h, respectively. (F) EtdBr-treated ceits 
shifted to drug-free medium for 23 days. For traces 
A-F, the concentrations of ceils (x 10’) per ml were 
15.9, 10.8, 9.9, 13.2, 9.6 and 10.5, respectively. 
and the cells continued to accumulate uro- and 
heptacarboxyporphyrins (table 1): EtdBr treat- 
ment of CEF results in the irreversible loss, to less 
than one copy per cell, of mtDNA molecules (in 
preparation). 
4. DISCUSSION 
This study demonstrates that long-term treat- 
ment of CEF with CAP and EtdBr results in 
disturbance of the decarboxylation of uropor- 
phyrinogen and in the accumulation of uro- and 
heptacarboxyporphyrins in the treated cells. It is a 
time-dependent process which becomes clearly evi- 
dent 2-3 weeks after the beginning of the treat- 
ment. The step-wise decrease in the capacity of 
CEF to decarboxylate uroporphyrinogen appears 
to accompany the step-wise decrease in the capaci- 
ty of the mitochondrial respiratory chain. When 
CAP is eliminated from the culture medium, the 
pattern of porphyrin production readily returns to 
normal as do protein synthesis on mitoribosomes 
and electron transport along the mitochondrial 
respiratory chain. In contrast, EtdBr-treated cells 
shifted to EtdBr-free medium remain uroporphyric 
and respiration deficient. These results suggest he 
possibility that impairment of respiration and/or 
other mitochondrial functions by xenobiotics can 
lead to uroporphyria development in tissues of 
those birds sensitive to the action of these 
compounds. 
That mitochondria can be involved in the 
development of uroporphyria is a possibility that 
has been evoked by other investigators [2,3,17]. 
However, no direct correlation has yet been 
established between the impairment of mitochon- 
drial functions and the generally accepted idea that 
uroporphyria induced in mammals and birds by 
xenobiotics is caused by decreased activity of 
uroporphyrinogen decarboxylase. Speculations on 
the mechanism of action of these compounds in- 
clude decreased synthesis and/or increased 
catabolism of uroporphyrinogen decarboxylase 
([18], but see [19]), direct inhibition of the enzyme 
by binding of the xenobiotics and/or their 
metaboiites to a group essential for catalytic activi- 
ty [20], inactivation of the enzyme by formation of 
oxygen radicals [21] and alterations of the redox 
state of the ceils leading to decreased ability to 
maintain uroporphyrinogen and/or the catalytic 
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thiol group of the enzyme in the reduced form 
(review [2]). Considering the fact that CEF can be 
cultivated for long periods in the presence of CAP 
and EtdBr and that the capacity of the cells to 
decarboxylate uroporphyrinogen can be modula- 
ted by CAP, CEF appear to provide a good model 
system to obtain some insight into these problems. 
Work is in progress to further our understanding 
of the development of uroporphyria in CEF. 
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